Literature DB >> 7658473

The three-dimensional crystal structure of cholera toxin.

R G Zhang1, D L Scott, M L Westbrook, S Nance, B D Spangler, G G Shipley, E M Westbrook.   

Abstract

The clinical manifestations of cholera are largely attributable to the actions of a secreted hexameric AB5 enterotoxin (choleragen). We have independently solved and refined the three-dimensional structure of choleragen at 2.5 A resolution. The structure of the crystalline toxin closely resembles that described for the heat-labile enterotoxin from Escherichia coli (LT) with which it shares 80% sequence homology. In both cases, the wedge-shaped A subunit is loosely held high above the plane of the pentameric B subunits by the tethering A2 chain. The most striking difference between the two toxins occurs at the carboxyl terminus of the A2 chain. Whereas the last 14 residues of the A2 chain of LT threading through the central pore of the B5 assembly form an extended chain with a terminal loop, the A2 chain of choleragen remains a nearly continuous alpha-helix throughout its length. The four carboxyl-terminal residues of the A2 chain (KDEL sequence), disordered in the crystal structure of LT, are clearly visible in choleragen's electron-density map. In the accompanying article we describe the three-dimensional structure of the isolated B pentamer of cholera toxin (choleragenoid). Comparison of the crystalline coordinates of choleragen, choleragenoid, and LT provides a solid three-dimensional foundation for further experimental investigation. These structures, along with those of related toxins from Shigella dysenteria and Bordetella pertussis, offer a first step towards the rational design of new vaccines and anti-microbial agents.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7658473     DOI: 10.1006/jmbi.1995.0456

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  111 in total

1.  Novel Approaches to Oral Vaccines: Delivery of Antigens by Edible Plants.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

2.  Directed polar secretion of protease from single cells of Vibrio cholerae via the type II secretion pathway.

Authors:  M E Scott; Z Y Dossani; M Sandkvist
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

Review 3.  Type II secretion and pathogenesis.

Authors:  M Sandkvist
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

4.  Studies on the immunogenic potential of plant-expressed cholera toxin B subunit.

Authors:  D Jani; N K Singh; S Bhattacharya; L S Meena; Y Singh; S N Upadhyay; A K Sharma; A K Tyagi
Journal:  Plant Cell Rep       Date:  2003-09-27       Impact factor: 4.570

5.  Cholera holotoxin assembly requires a hydrophobic domain at the A-B5 interface: mutational analysis and development of an in vitro assembly system.

Authors:  Juliette K Tinker; Jarrod L Erbe; Wim G J Hol; Randall K Holmes
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

Review 6.  The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology.

Authors:  Christopher J Guerriero; Jeffrey L Brodsky
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

7.  Intoxication of zebrafish and mammalian cells by cholera toxin depends on the flotillin/reggie proteins but not Derlin-1 or -2.

Authors:  David E Saslowsky; Jin Ah Cho; Himani Chinnapen; Ramiro H Massol; Daniel J-F Chinnapen; Jessica S Wagner; Heidi E De Luca; Wendy Kam; Barry H Paw; Wayne I Lencer
Journal:  J Clin Invest       Date:  2010-12       Impact factor: 14.808

8.  Expression of a cholera toxin B subunit-neutralizing epitope of the porcine epidemic diarrhea virus fusion gene in transgenic lettuce (Lactuca sativa L.).

Authors:  Nguyen-Xuan Huy; Moon-Sik Yang; Tae-Geum Kim
Journal:  Mol Biotechnol       Date:  2011-07       Impact factor: 2.695

Review 9.  Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents.

Authors:  S Ramasamy; C Q Liu; H Tran; A Gubala; P Gauci; J McAllister; T Vo
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

10.  Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems.

Authors:  Tetsuya Harakuni; Hideki Sugawa; Ai Komesu; Masayuki Tadano; Takeshi Arakawa
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.